MHRA

Corporate report: MHRA quarterly Results and Forecast: 2026 to 2027

MHRA (UK) · 15h ago

Class 4 Medicines Defect Notification: Star Pharmaceuticals Ltd, Enalapril maleate/ Hydrochlorothiazide 20 mg/12.5 mg Tablets, EL(26)A/48

MHRA (UK) · 16h ago

MHRA approves Retifanlimab (ZYNYZ) for the treatment of advanced anal cancer

MHRA (UK) · 1d ago

Register medical devices to place on the market

MHRA (UK) · 1d ago

Decision: Human and veterinary medicines: register of licensed manufacturing sites

MHRA (UK) · 2d ago

Decision: Human medicines: register of licensed wholesale distribution sites

MHRA (UK) · 2d ago

Decision: Human medicines: register of electronic export certificates

MHRA (UK) · 3d ago

MHRA grants Innovation Passports to three novel drugs

Pharmaphorum · 3d ago

Investigational treatments for lung cancer, Huntington’s disease and Alzheimer's gain Innovation Passports through the Innovative Licensing and Access Pathway

MHRA (UK) · 3d ago

Clinical investigations for medical devices

MHRA (UK) · 6d ago

Corporate report: Patient and Public Involvement and Engagement Plan 2026-2030

MHRA (UK) · 7d ago

MHRA sets out approach to strengthen patient and public involvement and engagement in medicines and medical device regulation

MHRA (UK) · 7d ago

Duvyzat®▼ (givinostat): interim advice on risk mitigation measures following reports of deaths in patients while taking givinostat

MHRA (UK) · 7d ago

Research brings Strep A vaccine ‘a step closer’, says MHRA

Pulse Today (UK GP) · 7d ago

Class 4 Medicines Defect Notification: Sandoz Limited, Co-Amoxiclav powder for oral suspension 250/62.5 mg/mL, EL(26)A/46

MHRA (UK) · 7d ago

randomized trial

Digital Mental Health Technologies (DMHT): Phase 1 evaluation survey

MHRA (UK) · 7d ago

MHRA guidance on its assessment of non-clinical data generated outside OECD system

MHRA (UK) · 8d ago

study

Use of non-OECD MAD non-clinical data in support of UK clinical trial authorisation applications

MHRA (UK) · 8d ago

Decision: Advertising investigations: October 2026

MHRA (UK) · 8d ago

Vertex wins MHRA backing for wider Casgevy use

PharmaTimes · 9d ago

Guidance: Herbal medicines granted a traditional herbal registration (THR)

MHRA (UK) · 10d ago

Domperidone prescribing guidance updated over severe hypertension risk

Pulse Today (UK GP) · 10d ago

MHRA launches patient safety essay competition for MedSafetyWeek

MHRA (UK) · 10d ago

Triheptanoin (Dojolvi) approved to treat adults and children with a group of rare inherited disorders

MHRA (UK) · 13d ago

MHRA approves gene-editing treatment for children aged five and over with serious inherited blood disorders

MHRA (UK) · 13d ago

Reading between the lines: The National AI Commission for the Regulation in Healthcare, and the UK Government’s response

Hardian Health · 15d ago

studyin animals

Needle-free Strep A vaccine triggers local and bodywide immune responses in mice

Medical Xpress · 16d ago

MHRA Safety Roundup: October 2026

MHRA (UK) · 16d ago

Decision: Medical devices given exceptional use authorisations

MHRA (UK) · 16d ago

Transparency data: MHRA Performance Data

MHRA (UK) · 16d ago

New MHRA research puts needle-free Strep A vaccine within reach

MHRA (UK) · 16d ago

Class 2 Medicines Recall: Xeal Pharma, Clopidogrel Oral Liquids (all strengths), EL(26)A/43

MHRA (UK) · 17d ago

MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults

MHRA (UK) · 20d ago

MHRA approves new oral treatment for moderate to severe plaque psoriasis

MHRA (UK) · 20d ago

Opportunities for patients and the public to be involved in the work of the MHRA

MHRA (UK) · 21d ago

review

IXCHIQ Chikungunya vaccine: UK marketing authorisation withdrawn following safety review

MHRA (UK) · 23d ago

MHRA authorises plozasiran (Redemplo) for adults with familial chylomicronaemia syndrome

MHRA (UK) · 24d ago

UK regulator brings new AI and MedTech agenda to AdvaMed

MHRA (UK) · 24d ago

Planning a Clinical Investigation? Don’t Underestimate the MHRA Notice of No Objection

Hardian Health · 78d ago

Do I need to notify the MHRA about my clinical investigation?

Hardian Health · 202d ago

Sources

Coverage